{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:32:47Z","timestamp":1792783967041,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81430025"],"award-info":[{"award-number":["81430025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81301102"],"award-info":[{"award-number":["81301102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Basic Scientific Research Fund of Northeastern University","award":["N120820001"],"award-info":[{"award-number":["N120820001"]}]},{"name":"Basic Scientific Research Fund of Northeastern University","award":["N130120002"],"award-info":[{"award-number":["N130120002"]}]},{"name":"Basic Scientific Research Fund of Northeastern University","award":["N142004003"],"award-info":[{"award-number":["N142004003"]}]},{"name":"Innovation Team Project of the Department of Education of Liaoning Province","award":["LT2015010"],"award-info":[{"award-number":["LT2015010"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.expneurol.2016.03.016","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T03:00:55Z","timestamp":1458270055000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Deferoxamine-mediated up-regulation of HIF-1\u03b1 prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice"],"prefix":"10.1016","volume":"280","author":[{"given":"Chuang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Juan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Li","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-You","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2016.03.016_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144848","article-title":"Iron chelators and antioxidants regenerate neuritic tree and nigrostriatal fibers of MPP+\/MPTP-lesioned dopaminergic neurons","volume":"10","author":"Aguirre","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0010","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1471-4159.1991.tb11444.x","article-title":"The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons","volume":"56","author":"Ben-Shachar","year":"1991","journal-title":"J. Neurochem."},{"issue":"32 Suppl.","key":"10.1016\/j.expneurol.2016.03.016_bb0015","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1002\/ana.410320718","article-title":"Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for Parkinson's disease","author":"Ben-Shachar","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0020","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1093\/nar\/27.21.4223","article-title":"HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation","volume":"27","author":"Bianchi","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nurt.2008.05.001","article-title":"Therapeutics for Alzheimer's disease based on the metal hypothesis","volume":"5","author":"Bush","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0030","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.3892\/ol.2014.2521","article-title":"Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase\/mitogen-activated protein kinase signaling pathway activity","volume":"8","author":"Chen","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0035","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1158\/0008-5472.CAN-04-1919","article-title":"C-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia","volume":"64","author":"Comerford","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0040","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1471-4159.1995.65020717.x","article-title":"A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains","volume":"65","author":"Connor","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0045","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","article-title":"Intramuscular desferrioxamine in patients with Alzheimer's disease","volume":"337","author":"Crapper McLachlan","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0050","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1749-6632.2000.tb06938.x","article-title":"Metal chelation as a potential therapy for Alzheimer's disease","volume":"920","author":"Cuajungco","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0055","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00702-010-0531-3","article-title":"Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration","volume":"118","author":"Dexter","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0065","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","article-title":"Increased nigral iron content in postmortem parkinsonian brain","volume":"2","author":"Dexter","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0070","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.expneurol.2013.03.017","article-title":"Chronic intranasal deferoxamine ameliorates motor defects and pathology in the alpha-synuclein rAAV Parkinson's model","volume":"247","author":"Febbraro","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0080","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1046\/j.1460-9568.2000.00044.x","article-title":"MPTP selectively induces haem oxygenase-1 expression in striatal astrocytes","volume":"12","author":"Fernandez-Gonzalez","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00221-012-3101-0","article-title":"Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1alpha, and phosphorylates GSK3beta in P301L tau transgenic mice","volume":"219","author":"Fine","year":"2012","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2014.05.048","article-title":"Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of parkinsons disease","volume":"1574","author":"Fine","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuroscience.2013.01.007","article-title":"Attenuation of MPTP\/MPP(+) toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposin","volume":"236","author":"Gao","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00702-010-0489-1","article-title":"Iron mediates neuritic tree collapse in mesencephalic neurons treated with 1-methyl-4-phenylpyridinium (MPP+)","volume":"118","author":"Gomez","year":"2011","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0105","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.45.6.1138","article-title":"Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease","volume":"45","author":"Gorell","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuint.2012.12.005","article-title":"Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain","volume":"62","author":"Guo","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.neurobiolaging.2012.05.009","article-title":"Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease","volume":"34","author":"Guo","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnagi.2015.00104","article-title":"Intranasal deferoxamine attenuates synapse loss via up-regulating the P38\/HIF-1alpha pathway on the brain of APP\/PS1 transgenic mice","volume":"7","author":"Guo","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0125","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/cdd.2008.188","article-title":"GAP-43 is essential for the neurotrophic effects of BDNF and positive AMPA receptor modulator S18986","volume":"16","author":"Gupta","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2131\/jts.38.25","article-title":"Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats","volume":"38","author":"Haleagrahara","year":"2013","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0135","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1042\/BST0351147","article-title":"Biochemistry of oxidative stress","volume":"35","author":"Halliwell","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0140","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/jpet.108.149807","article-title":"Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke","volume":"330","author":"Hanson","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0145","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1046\/j.1471-4159.2001.00160.x","article-title":"Is bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?","volume":"76","author":"Hartmann","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0150","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.51.2_Suppl_2.S2","article-title":"Biochemical aspects of Parkinson's disease","volume":"51","author":"Hornykiewicz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0155","doi-asserted-by":"crossref","first-page":"15240","DOI":"10.1074\/jbc.M312497200","article-title":"Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide","volume":"279","author":"Kalivendi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/bj20021525","article-title":"1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide","volume":"371","author":"Kalivendi","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0165","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0170","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuroscience.2011.03.040","article-title":"Novel molecular targets of the neuroprotective\/neurorescue multimodal iron chelating drug M30 in the mouse brain","volume":"189","author":"Kupershmidt","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0175","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0180","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/WNR.0000000000000356","article-title":"Hypoxia-inducible factor-1alpha upregulates tyrosine hydroxylase and dopamine transporter by nuclear receptor ERRgamma in SH-SY5Y cells","volume":"26","author":"Lim","year":"2015","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0185","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.nut.2009.11.022","article-title":"Protective effect of green tea (-)-epigallocatechin-3-gallate against the monoamine oxidase B enzyme activity increase in adult rat brains","volume":"26","author":"Lin","year":"2010","journal-title":"Nutrition"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0190","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s12013-014-0077-3","article-title":"Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson's disease","volume":"70","author":"Lv","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0195","doi-asserted-by":"crossref","first-page":"983245","DOI":"10.1155\/2012\/983245","article-title":"Chelators in the treatment of iron accumulation in Parkinson's disease","volume":"2012","author":"Mounsey","year":"2012","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0200","doi-asserted-by":"crossref","first-page":"23774","DOI":"10.1074\/jbc.270.40.23774","article-title":"Hypoxia-induced protein binding to O2-responsive sequences on the tyrosine hydroxylase gene","volume":"270","author":"Norris","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0205","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1212\/01.wnl.0000262033.01945.9a","article-title":"Individual dopaminergic neurons show raised iron levels in Parkinson disease","volume":"68","author":"Oakley","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0210","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1021\/ic7022727","article-title":"Predicting how polyphenol antioxidants prevent DNA damage by binding to iron","volume":"47","author":"Perron","year":"2008","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0215","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1096\/fj.00-0588fje","article-title":"Expression of human collagenase-3 (MMP-13) by fetal skin fibroblasts is induced by transforming growth factor beta via p38 mitogen-activated protein kinase","volume":"15","author":"Ravanti","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hipo.20045","article-title":"Hippocampal-dependent memory is impaired in heterozygous GAP-43 knockout mice","volume":"15","author":"Rekart","year":"2005","journal-title":"Hippocampus"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2008.07.001","article-title":"Genetics of iron regulation and the possible role of iron in Parkinson's disease","volume":"32","author":"Rhodes","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0230","doi-asserted-by":"crossref","first-page":"32631","DOI":"10.1074\/jbc.274.46.32631","article-title":"p42\/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1","volume":"274","author":"Richard","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0235","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1196\/annals.1306.026","article-title":"Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions","volume":"1012","author":"Richardson","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0240","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/jnr.1149","article-title":"Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental parkinsonism","volume":"65","author":"Rothblat","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0245","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.0804373105","article-title":"Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease","volume":"105","author":"Salazar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000065700","article-title":"Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alpha-synuclein translocation in SK-N-SH cells in culture","volume":"24","author":"Sangchot","year":"2002","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0255","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1046\/j.1471-4159.2000.0751200.x","article-title":"MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo","volume":"75","author":"Saporito","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0260","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1471-4159.2003.01696.x","article-title":"Regulation of tyrosine hydroxylase promoter activity by the von Hippel\u2013Lindau tumor suppressor protein and hypoxia-inducible transcription factors","volume":"85","author":"Schnell","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0265","doi-asserted-by":"crossref","first-page":"34451","DOI":"10.1074\/jbc.M202099200","article-title":"The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induces apoptosis in mouse nigrostriatal glia. Relevance to nigral neuronal death and striatal neurochemical changes","volume":"277","author":"Serra","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0270","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuropharm.2003.09.005","article-title":"Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats","volume":"46","author":"Shachar","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0275","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/ars.2009.3018","article-title":"Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease","volume":"13","author":"Shi","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0280","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.2741\/2892","article-title":"Prolyl 4-hydroxylase activity-responsive transcription factors: from hydroxylation to gene expression and neuroprotection","volume":"13","author":"Siddiq","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0285","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1471-4159.2006.03833.x","article-title":"Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway","volume":"97","author":"Teng","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0290","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pneurobio.2012.06.003","article-title":"Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson's disease","volume":"98","author":"Wang","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0295","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2013.01.017","article-title":"Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators","volume":"62","author":"Weinreb","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0300","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuint.2010.05.008","article-title":"Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells","volume":"57","author":"Wu","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0305","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1158\/1078-0432.CCR-0953-03","article-title":"Hypoxia-induced activation of p38 mitogen-activated protein kinase and phosphatidylinositol 3\u2032-kinase signaling pathways contributes to expression of interleukin 8 in human ovarian carcinoma cells","volume":"10","author":"Xu","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0310","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuroscience.2014.09.071","article-title":"Brain iron accumulation exacerbates the pathogenesis of MPTP-induced Parkinson's disease","volume":"284","author":"You","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0315","first-page":"57","article-title":"The role of iron in senescence of dopaminergic neurons in Parkinson's disease","volume":"40","author":"Youdim","year":"1993","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0320","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1196\/annals.1306.025","article-title":"Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28","volume":"1012","author":"Youdim","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0325","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/rej.2009.0908","article-title":"Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway","volume":"13","author":"Yu","year":"2010","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0330","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1471-4159.2008.05541.x","article-title":"Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease","volume":"106","author":"Zecca","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0335","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1479-5876-12-130","article-title":"Nerve growth factor improves functional recovery by inhibiting endoplasmic reticulum stress-induced neuronal apoptosis in rats with spinal cord injury","volume":"12","author":"Zhang","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0340","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.neurobiolaging.2007.11.025","article-title":"Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells","volume":"30","author":"Zhang","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2016.03.016_bb0345","first-page":"562","article-title":"Neuroprotection of desferrioxamine in lipopolysaccharide-induced nigrostriatal dopamine neuron degeneration","volume":"5","author":"Zhang","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.expneurol.2016.03.016_bb0350","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nbd.2009.09.024","article-title":"Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration","volume":"37","author":"Zhu","year":"2010","journal-title":"Neurobiol. Dis."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616300590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616300590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T22:44:39Z","timestamp":1718405079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488616300590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":70,"alternative-id":["S0014488616300590"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.03.016","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deferoxamine-mediated up-regulation of HIF-1\u03b1 prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}